|
Takeda has had a momentous few months, what with the launch of a multibillion-dollar
cash tender bid for Millennium Pharmaceuticals, the purchase of Japanese operations
and rights to a portfolio of products from Amgen and the dissolution of TAP Pharmaceutical,
its long-standing US joint venture with Abbott. |